"#OBIPharma Granted #FDA #OrphanDrugDesignation for the Treatment of #PancreaticCancer for Its #AntibodyDrugConjugate (#ADC) Targeted #CancerTherapy, #OBI999 https://t.co/MXAfR0vruq"

OBI-999 - OBI Pharma

Dec 28, 2019